Thyroid tumours of uncertain malignant potential: Frequency and diagnostic reproducibility

Virchows Archiv

Volumn 455, Issue 1, 2009, Pages 21-33

  Hofman, Véronique ^a,b,c   Lassalle, Sandra ^a,b,c   Bonnetaud, Christelle ^c   Butori, Catherine ^a,b,c   Loubatier, Céline ^c   Ilie, Marius ^c   Bordone, Olivier ^c   Brest, Patrick ^a,b   Guevara, Nicolas ^c   Santini, José ^c   Franc, Brigitte ^d,e   Hofman, Paul ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c PASTEUR HOSPITAL   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Follicular lesion; Molecular biology. Immunochemistry; Observer variation; Thyroid; Uncertain malignant potential tumour

Indexed keywords

B RAF KINASE; COMPLEMENTARY DNA; RNA;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FROZEN SECTION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; OBSERVER VARIATION; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; THYROID TUMOR; THYROIDECTOMY; TUMOR DIAGNOSIS; TUMOR VOLUME; UNCERTAINTY;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 67650713547     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0798-7     Document Type: Article

References (54)

1. ZW Baloch VA Livolsi 2002 Follicular-patterned lesions of the thyroid: the bane of the pathologist Am J Clin Pathol 117 143 150 (Pubitemid 34052484)
2. HL Evans 1984 Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis Cancer 54 535 540 (Pubitemid 14087884)
3. E Fonseca P Soares M Cardoso-Oliveira 2006 Diagnostic criteria in well-differentiated thyroid carcinomas Endocr Pathol 17 109 117 (Pubitemid 44965899)
4. VA Livolsi ZW Baloch 2004 Follicular neoplasms of the thyroid: view, biases, and experiences Adv Anat Pathol 11 279 287
5. J Rosai 2005 Handling of thyroid follicular patterned lesions Endocr Pathol 16 279 283
6. J Rosai E Kuhn ML Cargangiu 2006 Pitfalls in thyroid tumour pathology Histopathology 49 107 120 (Pubitemid 44079694)
7. M Sobrinho-Simões J Magalhaes E Foncesa 2005 Diagnostic pitfalls of thyroid pathology Curr Diag Pathol 11 52 59 (Pubitemid 40221909)
8. S Suster 2006 Thyroid tumours with a follicular growth pattern: problems in differential diagnosis Arch Pathol Lab Med 130 984 988 (Pubitemid 44061428)
9. VV Vasko J Gaudart C Allasia 2004 Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma Eur J Endocrinol 151 779 786 (Pubitemid 40090019)
10. B Franc P de la Salmonière F Lange 2003 Interobserver and intraobserver reproductibility in the histopathology of follicular thyroid carcinoma Hum Pathol 34 1092 1100 (Pubitemid 37466993)
11. M Hirokawa JA Carney JR Goellner 2002 Observer variation of encapsulated follicular lesions of the thyroid gland Am J Surg Pathol 26 1508 1514 (Pubitemid 35239428)
12. RV Lloyd LA Erickson MB Casey 2004 Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma Am J Surg Pathol 28 1336 1340 (Pubitemid 39336372)
13. De Lellis RA, Lloyd RV, Heitz PU (2004) Pathology and genetics: tumours and endocrine organs, 3rd edn. WHO, Geneva
14. ED Williams 2000 Guest editorial: two proposals regarding the terminology of thyroid tumours Int J Surg Pathol 8 181 183 (Pubitemid 30743757)
15. CC Cheung S Ezzat JL Freeman 2001 Immunohistochemical diagnosis of papillary thyroid carcinoma Mod Pathol 14 338 342 (Pubitemid 32298919)
16. S Fischer S Asa 2008 Application of immunochemistry to thyroid neoplasm Arch Pathol Lab Med 132 359 372
17. P Mehrotra A Okpokam R Bouhaidar 2004 Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasm Histopathology 45 493 500 (Pubitemid 39524324)
18. N Nakamura LA Erickson L Jin 2006 Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma Endocr Pathol 17 213 223
19. M Sobrino-Simoes A Preto AS Rocha 2005 Molecular pathology of well-differentiated thyroid carcinomas Virchows Arch 447 787 793 (Pubitemid 41728865)
20. ZW Baloch VA LiVolsi 2007 Our approach to follicular-patterned lesions of thyroid J Clin Pathol 60 244 250 (Pubitemid 46447737)
21. JE Barroeta ZW Baloch P Lal 2006 Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis Endocr Pathol 17 225 234 (Pubitemid 46279670)
22. A Coli G Bigotti P Parente 2007 Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma J Exp Clin Cancer Res 26 221 227 (Pubitemid 47025286)
23. Y Ito H Yoshida C Tomoda 2005 HBME-1 expression in follicular tumour of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma Anticancer Res 25 179 182 (Pubitemid 40470108)
24. T Mase H Funahashi T Koshikawa 2003 HBME-1 immunostaining in thyroid tumours especially in follicular neoplasm Endocrinol J 50 173 177 (Pubitemid 36554108)
25. M Miettinen P Karkkainen 1996 Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours Virchows Arch 429 213 219 (Pubitemid 26402663)
26. ML Prasad NS Pellegata Y Huang 2005 Galectin 3, fibronectin-1, CITED-1, HBME-1 and cytokeratin 19 immunochemistry is useful for the differential diagnosis of thyroid tumours Mod Pathol 18 48 57 (Pubitemid 40128094)
27. S Sahoo S Hoda J Rosai 2001 Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution Am J Clin Pathol 116 696 702 (Pubitemid 34453210)
28. L Torregrossa P Faviana T Camacci 2007 Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivity Hum Pathol 38 1482 1488 (Pubitemid 47418958)
29. A Bartolazzi A Gasbarri M Papotti 2001 Thyroid Cancer Study Group. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions Lancet 357 1644 1650 (Pubitemid 32568236)
30. A Bartolazzi F Orlandi E Saggiorato 2008 Galectin-3 expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study Lancet Oncol 9 543 549
31. JF Fontaine D Mirebeau-Prunier B Franc 2007 Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy Oncogene 29 1 9
32. M Papotti J Rodriguez R De Pompa 2005 Galectin-3 and HBME-1 expression in well-differentiated thyroid tumours with follicular architecture of uncertain malignant potential Mod Pathol 18 541 546 (Pubitemid 40478118)
33. V Rigau B Martel C Evrard 2001 HBME-1 immunostaining in thyroid pathology Ann Pathol 21 15 20 (Pubitemid 32199918)
34. T Scognamiglio E Hyjek J Kao 2006 Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma Am J Clin Pathol 126 700 708 (Pubitemid 44707620)
35. JK Chan 2002 Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma Am J Clin Pathol 117 16 18 (Pubitemid 34052466)
36. AA Renshaw EW Gould 2002 Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma Am J Clin Pathol 117 19 21 (Pubitemid 34052467)
37. P Castro AP Rebocho RJ Soares 2006 PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma J Clin Endocrinol Metab 91 213 220 (Pubitemid 43069140)
38. J Di Cristofaro M Marcy V Vasko 2006 Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant Hum Pathol 37 824 830 (Pubitemid 43902941)
39. R Elisei C Romei T Vorontsova 2001 RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults J Clin Endocrinol Metab 81 3211 3216 (Pubitemid 32673490)
40. A Fusco G Chiappetta P Hui 2002 Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer Am J Pathol 160 2157 2167 (Pubitemid 34663407)
41. TG Kroll P Sarraf L Pecciarini 2000 PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected] Science 289 1357 1360 (Pubitemid 30656054)
42. C Lupi R Giannini C Ugolini 2007 Association of B-RAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma J Clin Endocrinol Metab 92 4085 4090 (Pubitemid 350074715)
43. AR Marques C Espadinha AL Catarino 2002 Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas J Clin Endocrinol Metab 87 3947 3952 (Pubitemid 34879553)
44. YE Nikiforov 2002 RET-PTC rearrangement in thyroid tumours Endocr Pathol 13 3 16
45. P Soares V Trovisco AS Rocha 2003 B-RAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC Oncogene 22 4578 4580 (Pubitemid 36920701)
46. V Trovisco P Soares A Preto 2005 Type and prevalence of B-RAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness Virchows Arch 446 589 595 (Pubitemid 40922263)
47. V Vasko M Ferrand J Di Cristofaro 2003 Specific pattern of RAS oncogene mutations in follicular thyroid tumours J Clin Endocrinol Metab 88 2745 2752 (Pubitemid 36724451)
48. Z Zhu M Gandhi MN Nikiforova 2003 Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations Am J Clin Pathol 120 71 77 (Pubitemid 37046372)
49. KM Denning PC Smyth SF Cahill 2007 A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples Mod Pathol 20 1095 1102 (Pubitemid 47429201)
50. G Tallini G Brandao 2005 Assessment of RET/PTC oncogene activation in thyroid nodules utilizing laser capture microdissection followed by nested RT-PCR Methods Mol Biol 293 103 111
51. CB Barden KW Shister B Zhu 2003 3rd. Classification of follicular thyroid tumours by molecular signature: results of gene profiling Clin Cancer Res 9 1792 1800 (Pubitemid 36554606)
52. S Chevillard N Ugolin P Viehl 2004 Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications Clin Cancer Res 10 6586 6597 (Pubitemid 39346555)
53. DJ Finley B Zhu CB Barden 2004 Discrimination of benign and malignant thyroid nodules by molecular profiling Ann Surg 240 436 437
54. SP Finn P Smyth S Cahill 2007 Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy Virchows Arch 450 249 260 (Pubitemid 46376555)